Association between sleep duration and subsequent risk of Parkinson´s disease and survival: Data from NEDICES study
Objective: To evaluate whether sleep duration (i) is associated with a subsequent risk of Parkinson’ disease (PD); (ii) affects mortality rates in PD patients, using…The difference of the change of finger surface temperature after short time cold stress test between Parkinson disease and Multiple system atrophy
Objective: To examine whether there are differences of the change of finger surface temperature (FST) after short time cold stress test between Parkinson disease (PD),…Long-term efficacy and safety of incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions
Objective: SIAXI (NCT02091739), a pivotal double-blind, randomised, placebo-controlled study with a 48-week extension period (EP), assessed the efficacy and safety of incobotulinumtoxinA 75 U or…Low body weight is associated with poor functional status in Parkinson’s disease (PD)
Objective: To assess if low body weight and malnutrition is associated with poor functional status in PD. Background: It has been observed that many advanced…Salivary Alpha-Synuclein a new tool for the diagnosis of Parkinson’s disease?
Objective: The aim of the PARKSYN study was to test the utility of salivary alpha-synuclein (a-syn) concentration in the differential diagnosis between Parkinson's disease (PD)…Vascular risk factors prevalence differences between Vascular Parkinsonism (VaP) and Parkinson Disease (PD) in a hospital cross-section study
Objective: Determine and compare vascular risk factors between VaP and PD patients in a hospital-based sample. Background: Most studies demonstrate that vascular risk factors are…Correlation between mood and behavioral disorders and quality of life in patients with Parkinson’s disease
Objective: The aim of this study was to investigate if the mood and behavioral disorders could be correlate with quality of life in patients with…Rasch analysis of the Hospital Anxiety and Depression Scale among patients with early-stage Parkinson’s disease
Objective: We aim to assess the psychometric properties of the Korean version of Hospital Anxiety and Depression Scale (HADS) in a sample of early-stage Parkinson's…Safinamide in Parkinson’s disease
Objective: To evaluate clinical effects, safety and tolerability of safinamide add-on levodopa in Parkinson’s disease (PD) patients. Background: Safinamide is a recently approved adjunctive treatment…An evaluation of the availability and format of information provided to patients who have a new diagnosis of Parkinson’s disease (PD)
Objective: To evaluate if the information provided to a person with Parkinson’s (PwP) is relevant and appropriate for that individual. To also consider the need…
- « Previous Page
- 1
- …
- 278
- 279
- 280
- 281
- 282
- …
- 425
- Next Page »